Interferon triggers experimental synovitis and may potentiate auto-immune disease in humans
- PMID: 6207974
- DOI: 10.1007/BF02032343
Interferon triggers experimental synovitis and may potentiate auto-immune disease in humans
Abstract
From these data it appears that IFN is capable of stimulating prostaglandin E and hyaluronic acid production by human synovial fibroblasts in vitro and of initiating an inflammatory reaction in animal joints. In chronic arthritis its production may result from persisting viral or other antigenic stimulation. IFN may enhance the immune response and mediate the inflammatory process in the joint. Its role in the pathogenesis of rheumatic and various other autoimmune diseases is undergoing further study.
Similar articles
-
[New discoveries in joint disease etiology. Biochemical markers are promising].Lakartidningen. 1990 Sep 26;87(39):3074. Lakartidningen. 1990. PMID: 2215024 Swedish. No abstract available.
-
Immune interferon in the circulation of patients with autoimmune disease.N Engl J Med. 1979 Jul 5;301(1):5-8. doi: 10.1056/NEJM197907053010102. N Engl J Med. 1979. PMID: 449915
-
Role of adjuvants in turning autoimmunity into autoimmune disease.Scand J Rheumatol Suppl. 1995;101:179-81. doi: 10.3109/03009749509100923. Scand J Rheumatol Suppl. 1995. PMID: 7747123 Review.
-
Synovial lymphocytes and the aetiology of synovitis.Ann Rheum Dis. 1993 Mar;52 Suppl 1(Suppl 1):S17-21. doi: 10.1136/ard.52.suppl_1.s17. Ann Rheum Dis. 1993. PMID: 8481054 Free PMC article. Review. No abstract available.
-
Immunoglobulin G-induced experimental chronic immune synovitis: cell-mediated immunity to native interstitial collagen molecules and their constituent polypeptide chains.Cell Immunol. 1984 Sep;87(2):504-16. doi: 10.1016/0008-8749(84)90019-4. Cell Immunol. 1984. PMID: 6467385
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical